Estrogen Receptor Positive Breast Cancer Terminated Phase Trials for Zoledronic acid (DB00399)

Also known as: Oestrogen receptor positive breast cancer

IndicationStatusPhase
DBCOND0049177 (Estrogen Receptor Positive Breast Cancer)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01409811Biomarkers in Tissue Samples From Patients With Newly Diagnosed Breast Cancer Treated With Zoledronic AcidTreatment